Sage Therapeutics Inc (SAGE) — Working Capital to Net Assets Ratio
Sage Therapeutics Inc (SAGE) has a Working Capital to Net Assets ratio of 98.8% as of June 2025. Working capital of $364.44 Million (current assets of $409.08 Million minus current liabilities of $44.64 Million) is measured against net assets of $368.74 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See SAGE net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sage Therapeutics Inc Working Capital to Net Assets (2012–2024)
This chart shows how Sage Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of June 2025, the ratio stands at 98.8%, reflecting working capital of $364.44 Million against net assets of $368.74 Million USD. Check Sage Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Sage Therapeutics Inc (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sage Therapeutics Inc from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SAGE company net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.8% | $459.69 Million | $465.09 Million | $531.30 Million | $71.61 Million | ▲ +0.5 pp |
| 2023 | 98.4% | $786.60 Million | $799.53 Million | $869.35 Million | $82.75 Million | ▲ +4.7 pp |
| 2022 | 93.7% | $1.17 Billion | $1.25 Billion | $1.27 Billion | $99.26 Million | ▼ -5.6 pp |
| 2021 | 99.2% | $1.72 Billion | $1.73 Billion | $1.80 Billion | $85.19 Million | ▲ +0.0 pp |
| 2020 | 99.2% | $2.06 Billion | $2.07 Billion | $2.12 Billion | $67.20 Million | ▲ +1.5 pp |
| 2019 | 97.7% | $922.97 Million | $944.65 Million | $1.04 Billion | $112.13 Million | ▼ -1.8 pp |
| 2018 | 99.5% | $858.66 Million | $862.97 Million | $944.70 Million | $86.03 Million | ▼ 0.0 pp |
| 2017 | 99.5% | $473.12 Million | $475.48 Million | $525.08 Million | $51.95 Million | ▼ -0.2 pp |
| 2016 | 99.7% | $367.41 Million | $368.52 Million | $402.58 Million | $35.17 Million | ▼ 0.0 pp |
| 2015 | 99.7% | $173.18 Million | $173.69 Million | $188.49 Million | $15.31 Million | ▲ +0.4 pp |
| 2014 | 99.3% | $121.06 Million | $121.89 Million | $128.82 Million | $7.76 Million | ▲ +118.6 pp |
| 2013 | -19.3% | $6.09 Million | $-31.54 Million | $8.41 Million | $2.31 Million | ▼ -8.8 pp |
| 2012 | -10.5% | $1.41 Million | $-13.39 Million | $2.83 Million | $1.42 Million | — |